ENTA vs TGT · rev $65.3M vs P/E 17, rev $51.98B
Enanta Pharmaceuticals Inc (ENTA) versus Target Corporation (TGT) — a side-by-side from cached financials, not a winner call.
Enanta Pharmaceuticals Inc (ENTA) is a biotechnology company listed on US.
Target Corporation (TGT) is a discount stores company listed on NYSE. It is led by Michael J. Fiddelke.
Latest reported ENTA revenue for 2025-09-30 was $65.3M. Net income was -$81.9M. ENTA currently screens at market cap $328.0M.
Latest reported TGT revenue for 2026-08-01 was $51.98B. Net income was $2.66B. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
ENTA currently screens at market cap $328.0M. TGT currently screens at market cap $58.05B and trailing P/E 16.9.
Not investment advice. Open the ENTA and TGT stock pages for the full models.
Not investment advice.